
Acalabrutinib Approved in China for Chronic Lymphocytic Leukemia
September 5, 2023Kristi RosaThe National Medical Products Administration in China has approved acalabrutinib for use in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma w
Updated on: October 12,2023
87

Acalabrutinib Approved in China for Chronic Lymphocytic Leukemia
September 5, 2023Kristi RosaThe National Medical Products Administration in China has approved acalabrutinib for use in adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma w
Updated on:October 12,2023
87
